Literature DB >> 25414499

Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran.

Jens H Kuhn1, Loreen L Lofts2, Jeffrey R Kugelman2, Sophie J Smither3, Mark S Lever3, Guido van der Groen4, Karl M Johnson5, Sheli R Radoshitzky2, Sina Bavari2, Peter B Jahrling6, Jonathan S Towner7, Stuart T Nichol7, Gustavo Palacios2.   

Abstract

Ebola virus (EBOV) was discovered in 1976 around Yambuku, Zaire. A lack of nomenclature standards resulted in a variety of designations for each isolate, leading to confusion in the literature and databases. We sequenced the genome of isolate E718/ME/Ecran and unified the various designations under Ebola virus/H.sapiens-tc/COD/1976/Yambuku-Ecran.
Copyright © 2014 Kuhn et al.

Entities:  

Year:  2014        PMID: 25414499      PMCID: PMC4239354          DOI: 10.1128/genomeA.01178-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Ebola virus (EBOV) was discovered in 1976 around Yambuku, Équateur Province, Zaire (the present-day Democratic Republic of the Congo). Of the 318 people that became infected with the virus, 280 died (1). At least three EBOV isolates (Ecran, de Roover, and Mayinga) were obtained and distributed among laboratories for further characterization. Due to a lack of nomenclature standards, individual institutes assigned a variety of names to each individual isolate, thereby leading to confusion in the literature and in databases. Filovirus experts recently established a naming scheme for filoviruses (2, 3) and have designated reference isolates and sequences for each filovirus to facilitate research, automatic genome annotation, and database searches (4). Among these efforts are attempts to identify and remove possibly redundant isolate designations. Isolate E718 (known as 718 [5], E718 [6–14), E-718 [15-17], and E 718 [6, 15, 18–21]) is one of the EBOV isolates found in 1976. The origin of E718 is usually not mentioned, or it is stated only that E718 was derived from an acute-phase human blood sample (5, 10–14, 16, 17, 20, 21). Other authors elaborate that the isolate was obtained by S. R. Pattyn (Instituut voor Tropische Geneeskunde [ITG], Antwerp, Belgium) (6, 15, 18). One article refers to the isolate as the Zaire prototype (8), whereas a very recent publication states that “E718 [is] … one of four isolates (including … Mayinga)” (9). Finally, one publication states that E718 “was derived from a Zairean patient (ME) during the Zairean outbreak” (7). One of two publications detailing isolate ME states that this virus was “isolated by… Pattyn … Bowen, and … Webb from serum of adult female human being manifesting severe … illness” and that “[d]isease [was] contracted in Yambuku … and case transported to mission hospital in Kinshasa” (22). Other publications specify that patient ME was a 42-year-old woman who fell ill on 23 September 1976 in Yambuku and was transported by air to Kinshasa (23, 24). She died on 30 September 1976 (25, 26). From a review of internal documents at institutes that still store E718 cultures (CDC, Defence Science and Technology Laboratory [Dstl], ITG, and the United States Army Medical Research Institute of Infectious Diseases [USAMRIID]), detailed descriptions of the 1976 outbreak (25, 26), and personal observations of authors who participated in its control (K.M.J. and G.v.d.G.), we conclude that E718 is a synonym of ME. Both designations are, in all likelihood, synonyms of the EBOV variant designation Ecran (often incorrectly spelled Eckron in the literature), which is derived from the name of Sister Myriam (Louise Ecran), who was one of two nurses that were transported from Yambuku to Kinshasa (the other one being Sister Edmonda [Jeanne de Roover]) (25, 26). We sequenced E718 using infected cell-culture supernatant originally frozen at USAMRIID on 19 May 1978. Following sample preparation performed as described in Kugelman et al. (27), its sequence was determined with Ion Torrent PGM and Applied Biosystems Sanger technology with EBOV-specific oligonucleotides. The consensus genome was generated via reference alignment to that of RefSeq accession no. NC_002549 (Ebola virus/H.sapiens-tc/COD/1976/Yambuku-Mayinga [4]) using SeqMan Pro (DNAStar). As expected, the obtained sequence was nearly identical with that of RefSeq accession no. NC_002549 and has been deposited under the unifying designation Ebola virus/H.sapiens-tc/COD/1976/Yambuku-Ecran.

Nucleotide sequence accession numbers.

The GenBank accession no. of EBOV E718, now designated Ebola virus/H.sapiens-tc/COD/1976/Yambuku-Ecran, is KM655246.
  21 in total

1.  Ebola virus virulence for newborn mice.

Authors:  G van der Groen; W Jacob; S R Pattyn
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

2.  Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire.

Authors:  S Pattyn; G van der Groen; W Jacob; P Piot; G Courteille
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

3.  Plaque assay for Ebola virus.

Authors:  J B Moe; R D Lambert; H W Lupton
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

4.  Ebola and Marburg viruses: I. Some ultrastructural differences between strains when grown in Vero cells.

Authors:  D S Ellis; S Stamford; G Lloyd; E T Bowen; G S Platt; H Way; D I Simpson
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

5.  Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model.

Authors:  Sophie J Smither; Lin S Eastaugh; Jackie A Steward; Michelle Nelson; Robert P Lenk; Mark S Lever
Journal:  Antiviral Res       Date:  2014-01-24       Impact factor: 5.970

6.  Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection.

Authors:  A Baskerville; S P Fisher-Hoch; G H Neild; A B Dowsett
Journal:  J Pathol       Date:  1985-11       Impact factor: 7.996

7.  Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management.

Authors:  S P Fisher-Hoch; G S Platt; G Lloyd; D I Simpson; G H Neild; A J Barrett
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321

8.  Ebola haemorrhagic fever: experimental infection of monkeys.

Authors:  E T Bowen; G S Platt; D I Simpson; L B McArdell; R T Raymond
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

9.  Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.

Authors:  Jens H Kuhn; Yiming Bao; Sina Bavari; Stephan Becker; Steven Bradfute; J Rodney Brister; Alexander A Bukreyev; Kartik Chandran; Robert A Davey; Olga Dolnik; John M Dye; Sven Enterlein; Lisa E Hensley; Anna N Honko; Peter B Jahrling; Karl M Johnson; Gary Kobinger; Eric M Leroy; Mark S Lever; Elke Mühlberger; Sergey V Netesov; Gene G Olinger; Gustavo Palacios; Jean L Patterson; Janusz T Paweska; Louise Pitt; Sheli R Radoshitzky; Erica Ollmann Saphire; Sophie J Smither; Robert Swanepoel; Jonathan S Towner; Guido van der Groen; Viktor E Volchkov; Victoria Wahl-Jensen; Travis K Warren; Manfred Weidmann; Stuart T Nichol
Journal:  Arch Virol       Date:  2012-09-23       Impact factor: 2.574

10.  Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.

Authors:  Jens H Kuhn; Kristian G Andersen; Yīmíng Bào; Sina Bavari; Stephan Becker; Richard S Bennett; Nicholas H Bergman; Olga Blinkova; Steven Bradfute; J Rodney Brister; Alexander Bukreyev; Kartik Chandran; Alexander A Chepurnov; Robert A Davey; Ralf G Dietzgen; Norman A Doggett; Olga Dolnik; John M Dye; Sven Enterlein; Paul W Fenimore; Pierre Formenty; Alexander N Freiberg; Robert F Garry; Nicole L Garza; Stephen K Gire; Jean-Paul Gonzalez; Anthony Griffiths; Christian T Happi; Lisa E Hensley; Andrew S Herbert; Michael C Hevey; Thomas Hoenen; Anna N Honko; Georgy M Ignatyev; Peter B Jahrling; Joshua C Johnson; Karl M Johnson; Jason Kindrachuk; Hans-Dieter Klenk; Gary Kobinger; Tadeusz J Kochel; Matthew G Lackemeyer; Daniel F Lackner; Eric M Leroy; Mark S Lever; Elke Mühlberger; Sergey V Netesov; Gene G Olinger; Sunday A Omilabu; Gustavo Palacios; Rekha G Panchal; Daniel J Park; Jean L Patterson; Janusz T Paweska; Clarence J Peters; James Pettitt; Louise Pitt; Sheli R Radoshitzky; Elena I Ryabchikova; Erica Ollmann Saphire; Pardis C Sabeti; Rachel Sealfon; Aleksandr M Shestopalov; Sophie J Smither; Nancy J Sullivan; Robert Swanepoel; Ayato Takada; Jonathan S Towner; Guido van der Groen; Viktor E Volchkov; Valentina A Volchkova; Victoria Wahl-Jensen; Travis K Warren; Kelly L Warfield; Manfred Weidmann; Stuart T Nichol
Journal:  Viruses       Date:  2014-09-26       Impact factor: 5.048

View more
  14 in total

1.  Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model.

Authors:  Stuart D Dowall; Andrew Bosworth; Robert Watson; Kevin Bewley; Irene Taylor; Emma Rayner; Laura Hunter; Geoff Pearson; Linda Easterbrook; James Pitman; Roger Hewson; Miles W Carroll
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

2.  Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014.

Authors:  Jens H Kuhn; Kristian G Andersen; Sylvain Baize; Yīmíng Bào; Sina Bavari; Nicolas Berthet; Olga Blinkova; J Rodney Brister; Anna N Clawson; Joseph Fair; Martin Gabriel; Robert F Garry; Stephen K Gire; Augustine Goba; Jean-Paul Gonzalez; Stephan Günther; Christian T Happi; Peter B Jahrling; Jimmy Kapetshi; Gary Kobinger; Jeffrey R Kugelman; Eric M Leroy; Gael Darren Maganga; Placide K Mbala; Lina M Moses; Jean-Jacques Muyembe-Tamfum; Magassouba N'Faly; Stuart T Nichol; Sunday A Omilabu; Gustavo Palacios; Daniel J Park; Janusz T Paweska; Sheli R Radoshitzky; Cynthia A Rossi; Pardis C Sabeti; John S Schieffelin; Randal J Schoepp; Rachel Sealfon; Robert Swanepoel; Jonathan S Towner; Jiro Wada; Nadia Wauquier; Nathan L Yozwiak; Pierre Formenty
Journal:  Viruses       Date:  2014-11-24       Impact factor: 5.048

3.  Effectiveness of Four Disinfectants against Ebola Virus on Different Materials.

Authors:  Sophie Smither; Amanda Phelps; Lin Eastaugh; Sarah Ngugi; Lyn O'Brien; Andrew Dutch; Mark Stephen Lever
Journal:  Viruses       Date:  2016-07-07       Impact factor: 5.048

4.  Multiplexed Metagenomic Deep Sequencing To Analyze the Composition of High-Priority Pathogen Reagents.

Authors:  Michael R Wilson; Greg Fedewa; Mark D Stenglein; Judith Olejnik; Linda J Rennick; Sham Nambulli; Friederike Feldmann; W Paul Duprex; John H Connor; Elke Mühlberger; Joseph L DeRisi
Journal:  mSystems       Date:  2016-07-19       Impact factor: 6.496

5.  Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection.

Authors:  Stuart David Dowall; Jo Callan; Antra Zeltina; Ibrahim Al-Abdulla; Thomas Strecker; Sarah K Fehling; Verena Krähling; Andrew Bosworth; Emma Rayner; Irene Taylor; Sue Charlton; John Landon; Ian Cameron; Roger Hewson; Abdulsalami Nasidi; Thomas A Bowden; Miles W Carroll
Journal:  J Infect Dis       Date:  2015-12-28       Impact factor: 5.226

6.  Antiviral Screening of Multiple Compounds against Ebola Virus.

Authors:  Stuart D Dowall; Kevin Bewley; Robert J Watson; Seshadri S Vasan; Chandradhish Ghosh; Mohini M Konai; Gro Gausdal; James B Lorens; Jason Long; Wendy Barclay; Isabel Garcia-Dorival; Julian Hiscox; Andrew Bosworth; Irene Taylor; Linda Easterbrook; James Pitman; Sian Summers; Jenny Chan-Pensley; Simon Funnell; Julia Vipond; Sue Charlton; Jayanta Haldar; Roger Hewson; Miles W Carroll
Journal:  Viruses       Date:  2016-10-27       Impact factor: 5.048

7.  Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model.

Authors:  Joanna L Miller; Simon G Spiro; Stuart D Dowall; Irene Taylor; Antony Rule; Dominic S Alonzi; Andrew C Sayce; Edward Wright; Emma M Bentley; Ruth Thom; Graham Hall; Raymond A Dwek; Roger Hewson; Nicole Zitzmann
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

8.  Informing the Historical Record of Experimental Nonhuman Primate Infections with Ebola Virus: Genomic Characterization of USAMRIID Ebola Virus/H.sapiens-tc/COD/1995/Kikwit-9510621 Challenge Stock "R4368" and Its Replacement "R4415".

Authors:  Jeffrey R Kugelman; Cynthia A Rossi; Michael R Wiley; Jason T Ladner; Elyse R Nagle; Bradley P Pfeffer; Karla Garcia; Karla Prieto; Jiro Wada; Jens H Kuhn; Gustavo Palacios
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

9.  Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic.

Authors:  Stuart D Dowall; Andrew Bosworth; Emma Rayner; Irene Taylor; John Landon; Ian Cameron; Ruth Coxon; Ibrahim Al Abdulla; Victoria A Graham; Graham Hall; Gary Kobinger; Roger Hewson; Miles W Carroll
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

10.  Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus.

Authors:  Benjamin A Pinsky; Malaya K Sahoo; Johanna Sandlund; Marika Kleman; Medha Kulkarni; Per Grufman; Malin Nygren; Robert Kwiatkowski; Ellen Jo Baron; Fred Tenover; Blake Denison; Russell Higuchi; Reuel Van Atta; Neil Reginald Beer; Alda Celena Carrillo; Pejman Naraghi-Arani; Chad E Mire; Charlene Ranadheera; Allen Grolla; Nina Lagerqvist; David H Persing
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.